Monitoring Biosimilars
April 13, 2015
We speak with Professor Begoña Calvo from University of the Basque Country in Spain to find out more about her research into pharmacovigilance for biosimilars.
1 min read
April 13, 2015
We speak with Professor Begoña Calvo from University of the Basque Country in Spain to find out more about her research into pharmacovigilance for biosimilars.
1 min read
April 13, 2015
Previously, in our series – “Connecting the Dots in Drug Delivery” – we examined the current status of drug delivery. We saw how today’s new therapeutics pose tough challenges for formulation scientists, and how companies are tackling those challenges with a range of tools, from micronization to hot melt extrusion. But what techniques will be in the toolbox 10 years from now? We speak to academic and industry experts to find out.
1 min read
April 10, 2015
Sitting Down With… Phyllis Greenberger, President and CEO of the Society for Women’s Health Research (SWHR), Washington, D.C., USA.
1 min read
April 10, 2015
Glycan analysis poses major challenges for the biopharma industry; how can new technology lighten the load?
1 min read
April 10, 2015
As the world’s most populous country and the second largest global economy, the potential for growth is significant. But how does a company break into China?
1 min read
April 10, 2015
No-one likes getting injections. Fortunately, patients may soon have a pain-free alternative in the form of microneedle delivery systems – a hot area of research for our group and others around the world.
1 min read
April 9, 2015
The latest devices can deliver a drug in the right place and at the right time at the push of a button.
1 min read
April 7, 2015
The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.
1 min read
April 7, 2015
The industry has been dipping its toe into the water of continuous manufacturing for years. Are we finally ready to dive in?
1 min read
April 7, 2015
New and improved drugs are released every year to tackle global health needs – and many pharma companies have initiatives to supply those drugs to the developing world. Unfortunately, efforts are wasted without proper supply chain management. Here, we prioritize the top ten challenges.
1 min read
April 7, 2015
Legislation on pediatric medicines is sowing the seeds for a better future, but we must maintain momentum if children are to get the best possible care.
1 min read
April 7, 2015
$100 million pledged to kick start investment in new research
1 min read
April 7, 2015
FDA scolds company for revealing interim trial results
1 min read
April 7, 2015
Just how prevalent is pharmacogenomic information on European drug labels?
1 min read
April 7, 2015
New technology interprets slang and banter to find out what people really think
1 min read
April 7, 2015
An antimalarial medicine-making project wins the inaugural Humanity in Science Award
1 min read
April 7, 2015
Information from “stalled” drug trials should be published, not tossed aside
1 min read
April 7, 2015
It’s been a long road, but the FDA has finally given the nod to the first official biosimilar in the US
1 min read
April 7, 2015
Innovation in pharma isn’t synonymous with drug discovery
1 min read
False
False